Yin-qiong Huang
Yaofeng Wang
Keyue Hu1
Shu Lin
Xia-hong Lin- 1Department of Endocrinology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China
- 2Centre of Neurological and Metabolic Research, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China
- 3Diabetes and Metabolism Division, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney, NSW, Australia
- 4Department of Endocrinology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
Background: Obesity has been reported to lead to increased incidence of depression. Glycerol-3-phosphate acyltransferases 4 (GPAT4) is involved in triacylglycerol synthesis and plays an important role in the occurrence of obesity. GPAT4 is the only one of GPAT family expressed in the brain. The aim of this study is to investigate if central GPAT4 is associated with obesity-related depression and its underlying mechanism.
Results: A high-fat diet resulted in increased body weight and blood lipid. HFD induced depression like behavior in the force swimming test, tail suspension test and sucrose preference test. HFD significantly up-regulated the expression of GPAT4 in hippocampus, IL-1β, IL-6, TNF-α and NF-κB, accompanied with down-regulation of BDNF expression in hippocampus and ventromedical hypothalamus, which was attributed to AMP-activated protein kinase (AMPK) and cAMP-response element binding protein (CREB).
Conclusion: Our findings suggest that hippocampal GPAT4 may participate in HFD induced depression through AMPK/CREB/BDNF pathway, which provides insights into a clinical target for obesity-associated depression intervention.
Introduction
Obesity is a metabolic disorder caused by excessive accumulation of fat due to increased energy intake. Both environmental factors and genetic factors are responsible for the development of obesity (1, 2). With the development of social economy and lifestyle changes, the incidence of obesity is increasing over years, and it has become a serious public health problem. The main clinical consequences of obesity include diabetes, cardiovascular disease, respiratory distress syndrome, sleep disorders, asthma, and tumors, as well as various mental and psychological diseases (3, 4).
Both epidemiological and clinical studies have shown that there is a positive correlation between obesity and depression. Obese people have a significantly increased risk of depression (5, 6). Body mass index (BMI) is positively correlated with the degree of clinical depressive symptoms (7). However, although high-energy food can alleviate negative emotions and bad moods in a short period of time, the weight gain caused by long-term consumption will aggravate the depressive symptoms in patients (8, 9). Some scholars have also discovered that depression and obesity have the same candidate genes from the perspective of genetics. Depression and obesity have a high incidence of comorbidities, which seriously endanger the health of patients, but the mechanism is still unclear.
Obesity is related to a high-risk of depression. Both clinical studies and animal experiments have showed that there is a positive relationship between the two. However, the neuropathophysiological mechanism of depression caused by obesity remains unclear. Based on previous studies, neuroinflammation have been implicated in the development of depression. Inflammation, especially neuroinflammation, is an important link between obesity and depression. A high-fat diet activates the inflammatory response in the animal’s brain. Animal experiments have shown that IL-1β in the brain can mediate chronic stress-induced depression-like behaviors, while IL-1β receptor knockout mice will not show depression-like behaviors after stress (10).
Glycerol-3-Phosphate Acyltransferases 4 (GPAT4) is the key rate-limiting enzyme in the synthesis of triacylglycerols in the glycerophosphate pathway. Gene overexpression and gene knockout experiments (11, 12) confirmed that GPAT4 plays an important role in the development of obesity, liver steatosis and insulin resistance. Compared with wild-type mice, GPAT4-/- (gene knockout) mice lose weight, have subcutaneous lipodystrophy, reduce triacylglycerol (TAG) content in adipose tissue and liver, and improve insulin resistance (13). And a recent study (14) found that overexpression of GPAT4 in the liver of mice resulted in liver insulin resistance and thus impairs liver glucose metabolism, leading to increased liver gluconeogenesis and reduced glycogen synthesis, and ultimately destroys glucose homeostasis, indicating that GPAT4 may be a new drug target for potential prevention and treatment of obesity, insulin resistance and type 2 diabetes (15). GPAT4 is important in the development of obesity. Besides, GPAT4 is the only one in the GPAT family that is expressed in the brain (16, 17). However, whether central GPAT4 is involved in the development of depression remains unclear.
Brain-derived neurotrophic factor (BDNF) is mainly expressed in the central nervous system, especially in hippocampus and cortex. BDNF has been found to regulate food intake and energy metabolism in the central nervous system, promote body movement, suppress appetite, and improve the leptin resistance and insulin resistance (18). Besides, BDNF is also the main regulator of synaptic plasticity and memory formation (19). It is the major regulator of maintaining neuronal function, regeneration and repair, and preventing neuronal degeneration (20). Obese mice experienced a decline in cognitive function after a long-term high-fat diet, accompanied by corresponding pathological changes in hippocampal neurons, which are closely related to the decline of BDNF levels in hippocampus. Recent studies have found that obesity can induce hippocampal inflammation and impairs emotion related to the hippocampus (21).
High-fat-induced obese mice can lead to the inflammatory state in hippocampus of the mouse and the decrease of BDNF. Studies showed that GPAT4 is also highly expressed in the hippocampus, and GPAT4 is the key rate-limiting enzyme for the synthesis of triacylglycerols in the glycerophosphate pathway. Therefore, this study aims to investigate whether central GPAT4 is associated with obesity-related depression and its underlying mechanism.
Materials and Methods
Laboratory Animals and Reagents
Twenty-four 5-week-old male C57BL/6 mice were purchased from the Animal Experimental Center of Fujian Medical University. All mice were housed under standard conditions (constant temperature, constant humidity conditions, and a 12-h light/dark cycle), with free access to food and water. The study followed the National Guidelines for Laboratory Animal Welfare and was approved by the Experimental Animal Ethics Committee of the Second Affiliated Hospital of Fujian Medical University (2020-388).
Establishment of Mice Model
The twenty-four mice were acclimatized for 1 week before conducting the experiments. Then, they were randomized to two groups: normal diet group (ND group, n = 12) and high fat diet group (HFD group, n = 12). The ND group was fed a normal diet (Research Diets, D12450h), and the HFD group were fed a high-fat diet (Research Diets, D12451) for 8 weeks. Six mice in each group were subjected to brain tissue isolation for subsequent qPCR, and the remaining six mice were subjected to perfusion to make frozen sections of brain tissue for in situ hybridization.
Behavior Tests
Forced Swimming Test (FST)
The mice were forced to swim for 6 min in a transparent cylindrical container (40cm in height and 20cm in diameter) containing clean water (24°C, 20cm in depth). The duration of immobility state was measured (22).
Tail Suspension Test (TST)
In brief, the mice were suspended approximately 28 ± 2 cm off the floor by fixing its tail (2 cm from the tip of the tail) on the hook. During the experiment immobility time of the mice were automatically recorded for 6 mins (22, 23).
Sucrose Preference
Before starting the experiment, the mice were singly housed and trained to freely drink water and sucrose water in two bottles (the positions of the two water bottles were switched every day) and the daily intake of sucrose water and regular water was recorded for 1 week. The experiment was started after a stable sucrose water consumption was evident. After 21 days, the sucrose preference test was performed. The detailed test protocol was as follows: after a 12 h period of water fasting, the animals were allowed free access to two bottles respectively containing water and 1% sucrose solution. This test lasted for two hours. Sucrose preference was calculated as the ratio of sucrose water intake to the total volume of liquid intake (24, 25).
Lipid Measurement
Fasting lipid levels including total cholesterol, low density lipoprotein and triglyceride were measured with an automatic biochemistry analyzer.
In Situ Hybridization (ISH) by RNAscope Technology to Determine the mRNA Expression of BDNF in the Hippocampus and Ventromedical Hypothalamus
The animals were perfused with phosphate buffered solution (PBS) at a pH of 7.4 by a cannula inserted in the left ventricle after anesthesia, followed by 4% paraformaldehyde. After perfusion, the brains were immediately removed and were fixed in 4% paraformaldehyde in PBS at 4°C for 12 h and passed through 20 and 30% sucrose gradients prior to embedding in optimum cutting temperature compound (OCT). 20μm tissue sections were air-dried at −20°C and moved to −80°C for long-term storage. Commercially available RNAscope brown reagent kit and RNAscope probes (Advanced Cell Diagnostics, Hayward, CA, Cat No. 322300) were used for transcript detection. ISH was performed according to the manufacturer’s instructions for fixed-frozen tissue. The detection was operated in a hybridization oven (HybEZ™, ACD) with RNAscope Probe- Mm-BDNF (ACD 518751). Each set of probes contained a tag that enabled target transcription to be visualized in a brown color. To compare the expression differences between the two groups, we quantified the integral optical density (IOD) of positive BDNF staining using ImageJ and normalized it by stained area. The mean intensities from three random areas of the same size in target areas were measured for each probe.
Quantitative RT-PCR (qRT-PCR)
At the end of each experiment, a microdissection procedure was used to isolate hippocampus. Total RNA was extracted with TRIzol (RNAiso Plus) method (Takara, Japan). RNA was reversed transcribed into cDNA using the two-step method with PrimeScript™ RT reagent Kit with gDNA Eraser (Takara, Japan), according to the manufacturer’s instructions. mRNA qRT-PCR was performed with the TB Green™ Premix Ex Taq™ (TliRNaseH Plus) (Takara, Japan) according to the manufacturer’s instruction. The procedure was 95°C for 1 min; 95°C for 15 s and 60°C for 34 s, for 40 cycles; 95°C for 15 s, 60°C for 1 min and 95°C for 15 s. The primers were shown in (Table 1).
Table 1 Primers of qRT-PCR.
Statistical Analyses
All statistical analyses were performed using the SPSS Statistics 20 software. Data have been expressed in terms of mean ± standard deviation. Statistical significances between two groups of data were determined using unpaired, two-tailed Student’s t-test. A P value >0.05 was not considered significant, P value <0.05 was labeled as (*), P value <0.01 was labeled as (**), P value <0.001 was labeled as (***).
Results
Metabolic Phenotype in Dietary-Induced Obesity Mice
To determine the metabolic phenotype of mice after a fat-dense diet, we measure the body weight of mice every week. Besides, at the end the of experiment, blood lipid level was measured. We found that 8 weeks of high-fat diet caused increased body weight (Figures 1A, B), and blood lipid level including total cholesterol (Figure 1C), low density lipoprotein(Figure 1D), and triglyceride (Figure 1E), compared with ND group.
Figure 1 Body weight and blood lipid level after 8 weeks of HFD and ND. (A) body weight changes during the 8 weeks; (B) Body weight after 8 weeks; (C) total cholesterol; (D) low density lipoprotein; (E) triglyceride. Results are mean ± standard deviation, *P value < 0.05, **P value < 0.01, comparison between the mice fed HFD and ND. (n=6).
Depression-Like Phenotype in Dietary-Induced Obesity Mice
To determine whether the consumption of a fat-dense diet plays a causative role in the development of depression, we examined depression-related behaviors among mice fed a ND or HFD. After 8 weeks of high-fat diet (HFD), we examined depression-related behaviors including forced swimming test, tail suspension test and sucrose preference test. Increased immobilization time was observed during forced swim tests (Figure 2A) and tail suspension tests (Figure 2B) in HFD mice. Also, consumption of sucrose solution (Figure 2C) was less in HFD mice compared with control mice on a normal diet.
Figure 2 Depression-like phenotype in dietary-induced obesity mice. (A) forced swim tests; (B) tail suspension tests; (C) Sucrose preference test. *P value < 0.05, **P value < 0.01, comparison between the mice fed HFD and ND. (n=6).
GPAT4 Expression in Hippocampus Was Decreased After High Fat Diet
GPAT4 is the key rate-limiting enzyme in the synthesis of triacylglycerols in the glycerophosphate pathway and plays an important role in the development of obesity. Besides, GPAT4 is the only one in the GPAT family that is expressed in the brain. To investigate whether central GPAT4 is involved in the development of obesity-related depression, GPAT4 mRNA expression in hippocampus was measured after 8 weeks of high-fat diet (HFD). We found that compared with ND group, GPAT4 mRNA expression in hippocampus was significantly up-regulated in HFD group (Figure 3A). We further investigated the correlation between GPAT4 and body weight, we found that the GPAT4 was positive correlated with body weight (p<0.05) (Figure 3B)
Figure 3 (A) GPAT4 expression in hippocampus was decreased after high fat diet. **P value < 0.01, comparison between the mice fed HFD and ND.(B) Correlation between GPAT4 expression and body weight. (n=6).
High Fat Diet Induced Inflammation in Hippocampus
Inflammation, especially neuroinflammation, is an important link between obesity and depression. To measure the inflammation in the central nervous system, we examined inflammation markers between HFD mice and normal diet (ND) mice after 8 weeks of high-fat diet (HFD). We found that HFD significantly up-regulated the expression of IL-1β (Figure 4A), IL-6 (Figure 4B), TNF- α (Figure 4C) and NF-κB (Figure 4D) in hippocampus.
Figure 4 High fat diet induced inflammation in hippocampus. (A) IL-1β; (B) IL-6; (C) TNF- α; (D) NF-κB. *P value < 0.05, **P value < 0.01, comparison between the mice fed HFD and ND. (n=6).
BDNF Expression in Hippocampus and Ventromedical Hypothalamus Were Decreased After High Fat Diet
BDNF plays a role in emotion regulation, memory function and energy homeostasis as well. To evaluate the role of central BDNF in obesity-related depression, after 8 weeks of high-fat diet (HFD), we examined BDNF expression in hippocampus and ventromedical hypothalamus (VMH). Compared with ND group, BDNF mRNA expression in hippocampus (Figure 5), and VMH (Figure 6) were significantly down-regulated in HFD group.
Figure 5 (A) BDNF expression in hippocampus in ND group; (B) BDNF expression in hippocampus in HFD group; (C) percentage of positive area between ND and HFD group; (D) higher magnification of (A); (E) higher magnification of (B); (F) hippocampus area in the brain. ***P value < 0.001, comparison between the mice fed HFD and ND. (n=6).
Figure 6 (A) BDNF expression in VMH in ND group; (B) BDNF expression in VMH in HFD group; (C) percentage of positive area between ND group and HFD group; (D) higher magnification of (A); (E) higher magnification of (B); (F) VMH area in the brain. ***P value < 0.001, comparison between the mice fed HFD and ND. (n=6).
AMPK/CREB Pathway Might Participate in High Fat Diet Induced Depression
To further understand the molecular events underlying the high-fat diet induced depression-like behavior, q-RT PCR was carried out to measure the expression of AMPK and CREB mRNA expression. Our study showed that AMPK and CREB mRNA expression were decreased in HFD group compared with ND group (Figure 7).
Figure 7 (A) AMPK expression; (B) CREB expression. *P value < 0.05, comparison between the mice fed HFD and ND. (n=6).
Discussion
The main findings in our present study include (1) high-fat diet can lead to the development of depression through the use of behavioral paradigms; (2) its mechanism is related to the up-regulation of hippocampal GPAT4 expression and hippocampal inflammation; (3) in situ hybridization shows BDNF mRNA expression level, down-regulated in hippocampus and VMH; (4) Real-time quantitative PCR detects the down-regulation of hippocampal AMPK and CREB expression levels in the HFD fed mice.
Depression and obesity are closely related, interact, and are supported by a large amount of epidemiological evidence (26). A systematic review and meta-analysis of the longitudinal relationship between depression, overweight, and obesity discovered that obesity increases the risk of depression (27). Vagena et al. (28) discovered that a high-fat diet can promote the development of depression-like behavior in both groups of mice fed with a high-fat diet for 3 weeks and 8 weeks. In this study, we found that a high-fat diet for 8 weeks induces depression-like behavior, which is consistent with previous studies.
However, the specific mechanism of depression caused by obesity needs to be further explored. The hippocampus is a key area that controls emotions and cognitive behavior in the brain. In obese animal models, high levels of hippocampal and cortical cytokines are expressed in this area (29–31).
GPAT catalyze the first step of synthesis of TAG, which also acts as the rate-limiting enzyme in the de novo pathway of glycerophospholipid synthesis. Besides, GPAT4 is the only one in the GPAT family that is expressed in the brain including the hippocampus and the cerebellum. The present study reveals that high fat diet induced GPAT4 overexpression in hippocampus, suggesting that GPAT4 in the hippocampus might play a role in diet-induced depression.
Studies have shown that neurotrophins including BDNF have been documented to play a crucial role in depression. BDNF plays a role in emotion regulation and memory function, especially in the hippocampus area (32). The down-regulation of hippocampal BDNF levels is associated with impaired emotion-related behaviors (33). Many kinds of antidepressants and electroconvulsive therapies significantly increase the expression of BDNF in the hippocampus and prefrontal cortex (34). In addition, direct injection of BDNF into the hippocampus can also show antidepressant effects (35). BDNF plays an important regulatory role in the plasticity of hippocampal structure, and mediate protective effects by enhancing neuron survival (36). What’s more, the expression and signal transduction of hippocampal BDNF mRNA negatively regulated by proinflammatory cytokines (37–39). Dexamethasone can reduce the level of pro-inflammatory cytokines, increase the level of anti-inflammatory cytokines, and prevent the decline of BDNF level caused by inflammation (40). The expression of low levels of BDNF in the nervous system may trigger energy homeostasis, thereby developing obesity and glucose intolerance, and metabolic disorders. BDNF is an important part of the central nervous circuit and participates in regulating energy homeostasis (41). Integrate hippocampus BDNF signal affect the efficacy of antidepressants and the anxiety-like behavior (33).
Obviously, BDNF is related to depression. Previous studies found that the expression of BDNF in hippocampus decreased in depressed mice. However, it is not clear how high-fat diet affect BDNF expression in the central nervous system. In this study, we found that HFD simultaneously induced the down-regulation of BDNF mRNA in hippocampus and VMH, suggesting that BDNF may play a role in depression induced by high-fat diet.
VMH is the satiety center in the brain that regulates food intake, glucose and energy metabolism via different downstream targets. A recent research discovers the inhibition of peripheral 5-HT synthesis lead to resistance to HFD-induced obesity and can attenuate HFD-induced depression-like behavior (42).VMH is an important center that integrate peripheral metabolic signal (43). Our previous study found that high fat diet-fed mice with impaired glucose tolerance expressed lower level of BDNF mRNA in VMH. HFD leads to changes of BDNF in VMH by affecting the central insulin signaling pathway (44).
Obesity is linked with chronic low-grade inflammation, which actives the peripheral immunity, transform the inflammation in the central nervous system by the humoral, neural and cellular pathways (45). Central inflammation affects the pathophysiological process of depression, including monoaminergic neurotransmission. There were plenty of evidence justify the role of immune inflammatory disorders. A meta-analysis reported that the level of inflammation markers in depressed patients were higher than those in the control group (46–48). For patients with major depression with elevated plasma inflammatory markers, they respond poorly to antidepressant drugs (49). Higher IL-6 and CRP can predict the development of depression (50). Prospective researches also show that depression can predict the later level changes of IL-6 and CRP (51). A meta-analysis including14 randomized placebo controlled trials showed that anti-inflammatory treatments effectively reduce symptoms in patients with depression (52). Higher levels of peripheral IL-6 were related to brain inflammation (53, 54). IL-6 was negatively correlated with hippocampal gray matter volume in healthy adults (53), suggesting that inflammation was a contributing factor to the reduction of hippocampal gray matter. Peripheral inflammation affected hippocampal plasticity, which was due to the activation of microglia and the effects of IL-6 and TNF-α (55, 56). Brain inflammation may negatively affect emotion, study and memory through processes related to neurodegeneration and structural remodeling (57, 58), and mainly affected the hippocampus (59, 60).
5-AMP activated protein kinase (AMPK) is an enzyme involved in energy balance and glucose, and adipose metabolism to help maintain body homeostasis (61, 62). The activation of AMPK can increase the expression of BDNF and active CREB pathway (63). Depression model rats showed overexpression of miR-124 and down-regulation of CREB1 and BDNF in the hippocampus. While knocking down miR-124 improved depression-like behavior in depression rats, which might be related to the increased expression of CREB1 and BDNF in the hippocampus (64). Our study found out downregulation of AMPK and CREB in high-fat fed mice. Depression might be triggered by HFD through AMPK/CREB/BDNF pathway.
There are some limitations in our study. The connection between GPAT4 and BDNF still need to be further confirmed. In our future studies, we will use specific hippocampal GPAT4 knockout mice to further confirm the role of GPAT4 in the hippocampus in the development of depression.
In conclusion, we demonstrate that hippocampal GPAT4 might participate in HFD induced depression by activating AMPK, CREB and BDNF pathways, which provides insights into a clinical target for obesity-associated depression intervention (Figure 8).
Figure 8 HFD resulted in obesity and depression like behavior. After 8 weeks of HFD, hippocampus GPAT4 and inflammation increased, which was attributed to down-regulation of BDNF, AMP-activated protein kinase (AMPK) and cAMP-response element binding protein (CREB) expression in hippocampus. (n=6).
Data Availability Statement
All relevant data is contained within the article. Further inquiries can be directed to Y-qH by eWlucWlvbmdoQGZ1bXUuZWR1LmNu.
Ethics Statement
The animal study was reviewed and approved by the Experimental Animal Ethics Committee of the Second Affiliated Hospital of Fujian Medical University (2020-388).
Author Contributions
Y-qH, X-hL and SL conceptualized and designed these studies, performed them, and wrote the manuscript. KH and YW contributed through data analyses, data interpretation, and manuscript preparation. All authors contributed to the article and approved the submitted version.
Funding
Funding for this work was supported by the Natural science Foundation of Fujian Province (2020J01221); the Key Young Talents Health Training Project of Fujian Province (2020GGA057); Startup Fund for scientific research, Fujian Medical University (2016QH072); Miaopu Fund of the Second Affiliated Hospital of Fujian Medical University (2012MP45).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Herring MP, Sailors MH, Bray MS. Genetic Factors in Exercise Adoption, Adherence and Obesity. Obes Rev (2014) 15:29–39. doi: 10.1111/obr.12089
2. Jaaskelainen T, Paananen J, Lindstrom J, Eriksson JG, Tuomilehto J, Uusitupa M, et al. Genetic Predisposition to Obesity and Lifestyle Factors–the Combined Analyses of Twenty-Six Known BMI- and Fourteen Known Waist:Hip Ratio (WHR)-Associated Variants in the Finnish Diabetes Prevention Study. Br J Nutr (2013) 110:1856–65. doi: 10.1017/S0007114513001116
3. Gondoni LA, Titon AM, Silvestri G, Nibbio F, Taronna O, Ferrari P, et al. Short Term Effects of Physical Exercise and Low Calorie Diet on Left Ventricular Function in Obese Subjects: A Tissue Doppler Study. Nutr Metab Cardiovasc Dis (2007) 17:358–64. doi: 10.1016/j.numecd.2006.01.013
4. Masheb RM, Grilo CM, Rolls BJ. A Randomized Controlled Trial for Obesity and Binge Eating Disorder: Low-Energy-Density Dietary Counseling and Cognitive-Behavioral Therapy. Behav Res Ther (2011) 49:821–9. doi: 10.1016/j.brat.2011.09.006
5. Dong C, Sanchez LE, Price RA. Relationship of Obesity to Depression: A Family-Based Study. Int J Obes Relat Metab Disord (2004) 28:790–5. doi: 10.1038/sj.ijo.0802626
6. Hamer M, Batty GD, Kivimaki M. Risk of Future Depression in People Who are Obese But Metabolically Healthy: The English Longitudinal Study of Ageing. Mol Psychiatry (2012) 17:940–5. doi: 10.1038/mp.2012.30
7. Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, et al. Association Between Obesity and Psychiatric Disorders in the US Adult Population. Arch Gen Psychiatry (2006) 63:824–30. doi: 10.1001/archpsyc.63.7.824
8. Novick JS, Stewart JW, Wisniewski SR, Cook IA, Manev R, Nierenberg AA, et al. Clinical and Demographic Features of Atypical Depression in Outpatients With Major Depressive Disorder: Preliminary Findings From STAR*D. J Clin Psychiatry (2005) 66:1002–11. doi: 10.4088/JCP.v66n0807
9. Pagoto S, Schneider KL, Whited MC, Oleski JL, Merriam P, Appelhans B, et al. Randomized Controlled Trial of Behavioral Treatment for Comorbid Obesity and Depression in Women: The Be Active Trial. Int J Obes (Lond) (2013) 37:1427–34. doi: 10.1038/ijo.2013.25
10. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T, et al. Brain Interleukin-1 Mediates Chronic Stress-Induced Depression in Mice Via Adrenocortical Activation and Hippocampal Neurogenesis Suppression. Mol Psychiatry (2008) 13:717–28. doi: 10.1038/sj.mp.4002055
11. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes. Endocrine Rev (2002) 23:201–29. doi: 10.1210/edrv.23.2.0461
12. Takeuchi K, Reue K. Biochemistry, Physiology, and Genetics of GPAT, AGPAT, and Lipin Enzymes in Triglyceride Synthesis. Am J Physiol Endocrinol Metab (2009) 296:E1195–209. doi: 10.1152/ajpendo.90958.2008
13. Vergnes L, Beigneux AP, Davis R, Watkins SM, Young SG, Reue K. Agpat6 Deficiency Causes Subdermal Lipodystrophy and Resistance to Obesity. J Lipid Res (2006) 47:745–54. doi: 10.1194/jlr.M500553-JLR200
14. Shan D, Li JL, Wu L, Li D, Hurov J, Tobin JF, et al. GPAT3 and GPAT4 are Regulated by Insulin-Stimulated Phosphorylation and Play Distinct Roles in Adipogenesis. J Lipid Res (2010) 51:1971–81. doi: 10.1194/jlr.M006304
15. Zhang C, Cooper DE, Grevengoed TJ, Li LO, Klett EL, Eaton JM, et al. Glycerol-3-Phosphate Acyltransferase-4-Deficient Mice are Protected From Diet-Induced Insulin Resistance by the Enhanced Association of Mtor and Rictor. Am J Physiol Endocrinol Metab (2014) 307:E305–15. doi: 10.1152/ajpendo.00034.2014
16. Yu J, Loh K, Song ZY, Yang HQ, Zhang Y, Lin S. Update on Glycerol-3-Phosphate Acyltransferases: The Roles in the Development of Insulin Resistance. Nutr Diabetes (2018) 8:34. doi: 10.1038/s41387-018-0045-x
17. Chen YQ, Kuo MS, Li S, Bui HH, Peake DA, Sanders PE, et al. AGPAT6 is a Novel Microsomal Glycerol-3-Phosphate Acyltransferase. J Biol Chem (2008) 283:10048–57. doi: 10.1074/jbc.M708151200
18. Vanevski F, Xu B. Molecular and Neural Bases Underlying Roles of BDNF in the Control of Body Weight. Front Neurosci (2013) 7:37. doi: 10.3389/fnins.2013.00037
19. Stein S, Winnik S, Matter CM. Brain-Derived Neurotrophic Factor Val66Met Polymorphism in Depression and Thrombosis: SIRT1 as a Possible Mediator. Eur Heart J (2017) 38:1436–8. doi: 10.1093/eurheartj/ehv692
20. Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM. Serum BDNF Concentrations as Peripheral Manifestations of Depression: Evidence From a Systematic Review and Meta-Analyses on 179 Associations (N=9484). Mol Psychiatry (2014) 19:791–800. doi: 10.1038/mp.2013.105
21. Berry A, Mazzelli M, Musillo C, Riva MA, Cattaneo A, Cirulli F. High-Fat Diet During Adulthood Interacts With Prenatal Stress, Affecting Both Brain Inflammatory and Neuroendocrine Markers in Male Rats. Eur J Neurosci (2021). doi: 10.1111/ejn.15181
22. Shang C, Liu Z, Chen Z, Shi Y, Wang Q, Liu S, et al. BRAIN CIRCUITS. a Parvalbumin-Positive Excitatory Visual Pathway to Trigger Fear Responses in Mice. Science (2015) 348:1472–7. doi: 10.1126/science.aaa8694
23. Crowley JJ, Jones MD, O’Leary OF, Lucki I. Automated Tests for Measuring the Effects of Antidepressants in Mice. Pharmacol Biochem Behav (2004) 78:269–74. doi: 10.1016/j.pbb.2004.03.014
24. Forbes NF, Stewart CA, Matthews K, Reid IC. Chronic Mild Stress and Sucrose Consumption: Validity as a Model of Depression. Physiol Behav (1996) 60:1481–4. doi: 10.1016/S0031-9384(96)00305-8
25. Lin LY, Zhang J, Dai XM, Xiao NA, Wu XL, Wei Z, et al. Early-Life Stress Leads to Impaired Spatial Learning and Memory in Middle-Aged Apoe4-TR Mice. Mol Neurodegener (2016) 11:51. doi: 10.1186/s13024-016-0107-2
26. Milaneschi Y, Simmons WK, van Rossum EFC, Penninx BW. Depression and Obesity: Evidence of Shared Biological Mechanisms. Mol Psychiatry (2019) 24:18–33. doi: 10.1038/s41380-018-0017-5
27. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, Obesity, and Depression: A Systematic Review and Meta-Analysis of Longitudinal Studies. Arch Gen Psychiatry (2010) 67:220–9. doi: 10.1001/archgenpsychiatry.2010.2
28. Vagena E, Ryu JK, Baeza-Raja B, Walsh NM, Syme C, Day JP, et al. A High-Fat Diet Promotes Depression-Like Behavior in Mice by Suppressing Hypothalamic PKA Signaling. Transl Psychiatry (2019) 9:141. doi: 10.1038/s41398-019-0470-1
29. Dinel AL, Andre C, Aubert A, Ferreira G, Laye S, Castanon N. Cognitive and Emotional Alterations are Related to Hippocampal Inflammation in a Mouse Model of Metabolic Syndrome. PloS One (2011) 6:e24325. doi: 10.1371/journal.pone.0024325
30. Pistell PJ, Morrison CD, Gupta S, Knight AG, Keller JN, Ingram DK, et al. Cognitive Impairment Following High Fat Diet Consumption is Associated With Brain Inflammation. J Neuroimmunol (2010) 219:25–32. doi: 10.1016/j.jneuroim.2009.11.010
31. Erion JR, Wosiski-Kuhn M, Dey A, Hao S, Davis CL, Pollock NK, et al. Obesity Elicits Interleukin 1-Mediated Deficits in Hippocampal Synaptic Plasticity. J Neurosci (2014) 34:2618–31. doi: 10.1523/JNEUROSCI.4200-13.2014
32. Yamada K, Nabeshima T. Brain-Derived Neurotrophic Factor/Trkb Signaling in Memory Processes. J Pharmacol Sci (2003) 91:267–70. doi: 10.1254/jphs.91.267
33. Martinowich K, Manji H, Lu B. New Insights Into BDNF Function in Depression and Anxiety. Nat Neurosci (2007) 10:1089–93. doi: 10.1038/nn1971
34. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and Trkb Mrna in Rat Brain by Chronic Electroconvulsive Seizure and Antidepressant Drug Treatments. J Neurosci (1995) 15:7539–47. doi: 10.1523/JNEUROSCI.15-11-07539.1995
35. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression. J Neurosci (2002) 22:3251–61. doi: 10.1523/JNEUROSCI.22-08-03251.2002
36. Suri D, Vaidya VA. Glucocorticoid Regulation of Brain-Derived Neurotrophic Factor: Relevance to Hippocampal Structural and Functional Plasticity. Neuroscience (2013) 239:196–213. doi: 10.1016/j.neuroscience.2012.08.065
37. Barrientos RM, Sprunger DB, Campeau S, Watkins LR, Rudy JW, Maier SF. BDNF Mrna Expression in Rat Hippocampus Following Contextual Learning is Blocked by Intrahippocampal IL-1beta Administration. J Neuroimmunol (2004) 155:119–26. doi: 10.1016/j.jneuroim.2004.06.009
38. Tanaka S, Ide M, Shibutani T, Ohtaki H, Numazawa S, Shioda S, et al. Lipopolysaccharide-Induced Microglial Activation Induces Learning and Memory Deficits Without Neuronal Cell Death in Rats. J Neurosci Res (2006) 83:557–66. doi: 10.1002/jnr.20752
39. Tong L, Balazs R, Soiampornkul R, Thangnipon W, Cotman CW. Interleukin-1 Beta Impairs Brain Derived Neurotrophic Factor-Induced Signal Transduction. Neurobiol Aging (2008) 29:1380–93. doi: 10.1016/j.neurobiolaging.2007.02.027
40. Horita J, da Silva MCM, Ferrari CZ, Vieira ELM, Moreira FA, de Oliveira ACP, et al. Evaluation of Brain Cytokines and the Level of Brain-Derived Neurotrophic Factor in an Inflammatory Model of Depression. Neuroimmunomodulation (2020) 27:86–96. doi: 10.1159/000511181
41. Benarroch EE. Neural Control of Feeding Behavior: Overview and Clinical Correlations. Neurology (2010) 74:1643–50. doi: 10.1212/WNL.0b013e3181df0a3f
42. Karth MM, Baugher BJ, Daly N, Karth MD, Gironda SC, Sachs BD. Brain 5-HT Deficiency Prevents Antidepressant-Like Effects of High-Fat-Diet and Blocks High-Fat-Diet-Induced GSK3beta Phosphorylation in the Hippocampus. Front Mol Neurosci (2019) 12:298. doi: 10.3389/fnmol.2019.00298
43. Zhang J, Chen D, Sweeney P, Yang Y. An Excitatory Ventromedial Hypothalamus to Paraventricular Thalamus Circuit That Suppresses Food Intake. Nat Commun (2020) 11:6326. doi: 10.1038/s41467-020-20093-4
44. Zhang Y, Zhang SW, Khandekar N, Tong SF, Yang HQ, Wang WR, et al. Reduced Serum Levels of Oestradiol and Brain Derived Neurotrophic Factor in Both Diabetic Women and HFD-Feeding Female Mice. Endocrine (2017) 56:65–72. doi: 10.1007/s12020-016-1197-x
45. Capuron L, Miller AH. Immune System to Brain Signaling: Neuropsychopharmacological Implications. Pharmacol Ther (2011) 130:226–38. doi: 10.1016/j.pharmthera.2011.01.014
46. Hiles SA, Baker AL, de Malmanche T, Attia J. Interleukin-6, C-Reactive Protein and Interleukin-10 After Antidepressant Treatment in People With Depression: A Meta-Analysis. Psychol Med (2012) 42:2015–26. doi: 10.1017/S0033291712000128
47. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A Meta-Analysis of Cytokines in Major Depression. Biol Psychiatry (2010) 67:446–57. doi: 10.1016/j.biopsych.2009.09.033
48. Howren MB, Lamkin DM, Suls J. Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis. Psychosom Med (2009) 71:171–86. doi: 10.1097/PSY.0b013e3181907c1b
49. Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression: The Role of Baseline Inflammatory Biomarkers. JAMA Psychiatry (2013) 70:31–41. doi: 10.1001/2013.jamapsychiatry.4
50. Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and Depression: A Systematic Review and Meta-Analysis of Longitudinal Studies. J Affect Disord (2013) 150:736–44. doi: 10.1016/j.jad.2013.06.004
51. Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ. Cumulative Depression Episodes Predict Later C-Reactive Protein Levels: A Prospective Analysis. Biol Psychiatry (2012) 71:15–21. doi: 10.1016/j.biopsych.2011.09.023
52. Kohler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, et al. Effect of Anti-Inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. JAMA Psychiatry (2014) 71:1381–91. doi: 10.1001/jamapsychiatry.2014.1611
53. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR. Interleukin-6 Covaries Inversely With Hippocampal Grey Matter Volume in Middle-Aged Adults. Biol Psychiatry (2008) 64:484–90. doi: 10.1016/j.biopsych.2008.04.016
54. Andre C, O’Connor JC, Kelley KW, Lestage J, Dantzer R, Castanon N. Spatio-Temporal Differences in the Profile of Murine Brain Expression of Proinflammatory Cytokines and Indoleamine 2,3-Dioxygenase in Response to Peripheral Lipopolysaccharide Administration. J Neuroimmunol (2008) 200:90–9. doi: 10.1016/j.jneuroim.2008.06.011
55. Savage JC, St-Pierre MK, Hui CW, Tremblay ME. Microglial Ultrastructure in the Hippocampus of a Lipopolysaccharide-Induced Sickness Mouse Model. Front Neurosci (2019) 13:1340. doi: 10.3389/fnins.2019.01340
56. Kohler CA, Freitas TH, Stubbs B, Maes M, Solmi M, Veronese N, et al. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis. Mol Neurobiol (2018) 55:4195–206. doi: 10.1007/s12035-017-0632-1
57. Hein AM, Stasko MR, Matousek SB, Scott-McKean JJ, Maier SF, Olschowka JA, et al. Sustained Hippocampal IL-1beta Overexpression Impairs Contextual and Spatial Memory in Transgenic Mice. Brain Behav Immun (2010) 24:243–53. doi: 10.1016/j.bbi.2009.10.002
58. Noble F, Rubira E, Boulanouar M, Palmier B, Plotkine M, Warnet JM, et al. Acute Systemic Inflammation Induces Central Mitochondrial Damage and Mnesic Deficit in Adult Swiss Mice. Neurosci Lett (2007) 424:106–10. doi: 10.1016/j.neulet.2007.07.005
59. Monje ML, Toda H, Palmer TD. Inflammatory Blockade Restores Adult Hippocampal Neurogenesis. Science (2003) 302:1760–5. doi: 10.1126/science.1088417
60. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH. Progressive Decline in Avoidance Learning Paralleled by Inflammatory Neurodegeneration in Transgenic Mice Expressing Interleukin 6 in the Brain. Proc Natl Acad Sci United States America (1997) 94:1500–5. doi: 10.1073/pnas.94.4.1500
61. Lopez M, Nogueiras R, Tena-Sempere M, Dieguez C. Hypothalamic AMPK: A Canonical Regulator of Whole-Body Energy Balance. Nat Rev Endocrinol (2016) 12:421–32. doi: 10.1038/nrendo.2016.67
62. Hardie DG, Ross FA, Hawley SA. AMPK: A Nutrient and Energy Sensor That Maintains Energy Homeostasis. Nat Rev Mol Cell Biol (2012) 13:251–62. doi: 10.1038/nrm3311
63. West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz AJ, et al. Calcium Regulation of Neuronal Gene Expression. Proc Natl Acad Sci United States America (2001) 98:11024–31. doi: 10.1073/pnas.191352298
Keywords: glycerol-3-phosphate acyltransferases 4, depression, high fat diet, hippocampus, ventromedical hypothalamus, inflammation
Citation: Huang Y-q, Wang Y, Hu K, Lin S and Lin X-h (2021) Hippocampal Glycerol-3-Phosphate Acyltransferases 4 and BDNF in the Progress of Obesity-Induced Depression. Front. Endocrinol. 12:667773. doi: 10.3389/fendo.2021.667773
Received: 14 February 2021; Accepted: 19 April 2021;
Published: 13 May 2021.
Edited by:
Tiemin Liu, Fudan University, ChinaReviewed by:
Qingchun Tong, University of Texas Health Science Center at Houston, United StatesRomana Stark, Monash University, Australia
Copyright © 2021 Huang, Wang, Hu, Lin and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xia-hong Lin, bGlueGlhaG9uZ2RyQGZqbXUuZWR1LmNu; Shu Lin, c2h1bGluMTk1NkAxMjYuY29t